Intravenous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects
Clinical trial NCT06025851 · COMPLETED
Trial details
- NCT number
- NCT06025851
- Sponsor
- ChemomAb Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-24
- Primary completion
- 2018-02-18
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.